Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing

dc.contributor.authorThompson, Erika L.
dc.contributor.authorGalvin, Annalynn M.
dc.contributor.authorDaley, Ellen M.
dc.contributor.authorTatar, Ovidiu
dc.contributor.authorZimet, Gregory D.
dc.contributor.authorRosberger, Zeev
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2020-01-31T19:14:39Z
dc.date.available2020-01-31T19:14:39Z
dc.date.issued2020-01
dc.description.abstractCervical cancer screening guidelines in the United States were revised in 2018 to include the option of primary human papillomavirus (HPV) testing. The transition to this screening method may face difficulties as Pap testing has been the primary screening modality in the United States. The objective of this study is to assess information, motivation, and behavioral skills associated with willingness to receive an HPV test instead of a Pap test among women. The sample included U.S. 812 women, ages 30 to 65 years. Participants completed an online survey in 2018. The Information, Motivation, and Behavioral Skills (IMB) model was used to measure predictors of willingness for HPV testing. The outcome variables were willingness to receive the HPV test instead of the Pap test, with and without time interval details. Logistic regression modeling was used with SAS 9.4. Over half of the sample (55%) were willing to receive the HPV test. For the information domain, HPV knowledge was significantly associated with willingness for HPV testing (OR = 1.08, 95%CI 1.04–1.13). Significant motivating factors included: positive attitudes, social norms, perceived benefits, worry about cervical cancer, and worry about abnormal HPV tests. For behavioral skills, women were significantly more willing to get the HPV test if a provider recommended it (OR = 2.43, 95%CI 1.53–3.87) and currently up-to-date on cervical cancer screening guidelines (OR = 1.52, 95%CI 1.52–2.26). Addressing barriers and facilitators to willingness to transition to primary HPV testing over Pap testing is needed as the United States has updated guidelines for cervical cancer screening.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationThompson, E. L., Galvin, A. M., Daley, E. M., Tatar, O., Zimet, G. D., & Rosberger, Z. (2020). Recent changes in cervical cancer screening guidelines: U.S. women’s willingness for HPV testing instead of Pap testing. Preventive Medicine, 130, 105928. https://doi.org/10.1016/j.ypmed.2019.105928en_US
dc.identifier.urihttps://hdl.handle.net/1805/21961
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.ypmed.2019.105928en_US
dc.relation.journalPreventive Medicineen_US
dc.rightsPublisher Policyen_US
dc.sourcePublisheren_US
dc.subjecthuman papillomavirusen_US
dc.subjectcervical canceren_US
dc.subjectscreeningen_US
dc.titleRecent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testingen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Thompson_2019_recent.pdf
Size:
520.33 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: